Literature DB >> 9684787

Early identification and prognostic implications in disseminated intravascular coagulation through transmittance waveform analysis.

C Downey1, R Kazmi, C H Toh.   

Abstract

Efforts to improve the prognosis in disseminated intravascular coagulation (DIC) have been hampered by the lack of an early, useful and rapidly available diagnostic marker. More recently, a characteristic bi-phasic change in the light transmittance waveform profile of the APTT assay has been associated with DIC. In this prospective study, we have assessed the utility of this assay in the routine clinical setting. 1,470 samples were analysed from 747 patients and 41 patients had DIC. The sensitivity and specificity of the bi-phasic waveform pattern for DIC was 97.6% and 98% respectively. The appearance of a bi-phasic waveform preceded the development of abnormalities in the standard laboratory tests for DIC and waveform changes correlated closely with clinical events. In conclusion, transmittance waveform analysis is not only useful as an early diagnostic and single monitoring marker of DIC but the quantifiable and standardisable changes also allow for prognostic applicability in clinical management.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9684787

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  11 in total

Review 1.  Mannose-binding lectin and the balance between immune protection and complication.

Authors:  Kazue Takahashi
Journal:  Expert Rev Anti Infect Ther       Date:  2011-12       Impact factor: 5.091

2.  Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation.

Authors:  Kazue Takahashi; Wei-Chuan Chang; Minoru Takahashi; Vasile Pavlov; Yumi Ishida; Laura La Bonte; Lei Shi; Teizo Fujita; Gregory L Stahl; Elizabeth M Van Cott
Journal:  Immunobiology       Date:  2010-03-04       Impact factor: 3.144

Review 3.  DIC in Pregnancy - Pathophysiology, Clinical Characteristics, Diagnostic Scores, and Treatments.

Authors:  Offer Erez; Maha Othman; Anat Rabinovich; Elad Leron; Francesca Gotsch; Jecko Thachil
Journal:  J Blood Med       Date:  2022-01-06

4.  Elevated plasma CL-K1 level is associated with a risk of developing disseminated intravascular coagulation (DIC).

Authors:  Kazue Takahashi; Katsuki Ohtani; Mykol Larvie; Patience Moyo; Lorencia Chigweshe; Elizabeth M Van Cott; Nobutaka Wakamiya
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

5.  Effect of cardiopulmonary bypass on activated partial thromboplastin time waveform analysis, serum procalcitonin and C-reactive protein concentrations.

Authors:  Bertrand Delannoy; Marie-Laurence Guye; Davy Hay Slaiman; Jean-Jacques Lehot; Maxime Cannesson
Journal:  Crit Care       Date:  2009-11-13       Impact factor: 9.097

Review 6.  A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis.

Authors:  Marcus D Lancé
Journal:  Thromb J       Date:  2015-01-12

Review 7.  Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines.

Authors:  Hideo Wada; Takeshi Matsumoto; Yoshiki Yamashita
Journal:  J Intensive Care       Date:  2014-02-20

Review 8.  Dysregulation of coagulation in cerebral malaria.

Authors:  Christopher Alan Moxon; Robert Simon Heyderman; Samuel Crocodile Wassmer
Journal:  Mol Biochem Parasitol       Date:  2009-03-26       Impact factor: 1.759

Review 9.  Disseminated intravascular coagulation.

Authors:  A Venugopal
Journal:  Indian J Anaesth       Date:  2014-09

10.  Assessment of aPTT-based clot waveform analysis for the detection of haemostatic changes in different types of infections.

Authors:  Chuen Wen Tan; Wan Hui Wong; McVin Hua Heng Cheen; Yvonne Miao Hui Chu; Shan Shan Lim; Lawrence Cheng Kiat Ng; Dillon Guo Dong Yeo; Gayathry Morvil; Lai Heng Lee; Heng Joo Ng
Journal:  Sci Rep       Date:  2020-08-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.